| SpectraBase Spectrum ID |
5WGa4Hdt9Ps |
| Name |
MO-CHMINACA |
| Classification |
Indazole cannabinoid designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
386.220557450 u |
| Formula |
C22H30N2O4 |
| InChI |
InChI=1S/C22H30N2O4/c1-22(2,3)19(21(26)27-4)28-20(25)18-16-12-8-9-13-17(16)24(23-18)14-15-10-6-5-7-11-15/h8-9,12-13,15,19H,5-7,10-11,14H2,1-4H3 |
| InChIKey |
SUEOBRAXHJBVGY-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
386.492 g/mol |
| Nominal Mass |
386 u |
| Quality |
998 |
| Retention Index |
2722 |
| SMILES |
C=1(C=2C(N(N1)CC1CCCCC1)=CC=CC2)C(OC(C(C)(C)C)C(OC)=O)=O |
| SPLASH |
splash10-0a4m-3962000000-3e91026e023c92459524 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
MO-AMB
1-Methoxy-3,3-dimethyl-1-oxo-2-butanyl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate
[1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl]1-(cyclohexylmethyl)-1H-indazole-3-carboxylate |
| Technique |
GC/MS |
| Wiley ID |
DD2024_022796 |
